US20070141333A1 - Emulsion-based control of electrospun fiber morphology - Google Patents
Emulsion-based control of electrospun fiber morphology Download PDFInfo
- Publication number
- US20070141333A1 US20070141333A1 US10/594,094 US59409405A US2007141333A1 US 20070141333 A1 US20070141333 A1 US 20070141333A1 US 59409405 A US59409405 A US 59409405A US 2007141333 A1 US2007141333 A1 US 2007141333A1
- Authority
- US
- United States
- Prior art keywords
- poly
- component
- fiber
- emulsion
- evaporation rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 106
- 239000000839 emulsion Substances 0.000 title claims abstract description 60
- 238000000034 method Methods 0.000 claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 46
- 238000001704 evaporation Methods 0.000 claims abstract description 35
- 230000008020 evaporation Effects 0.000 claims abstract description 35
- 229920000642 polymer Polymers 0.000 claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- -1 poly(vinyl alcohol) Polymers 0.000 claims description 81
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 52
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 32
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 20
- 238000001523 electrospinning Methods 0.000 claims description 19
- 239000002245 particle Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 210000004027 cell Anatomy 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 230000006872 improvement Effects 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 5
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- 230000000975 bioactive effect Effects 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- 239000001506 calcium phosphate Substances 0.000 claims description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 4
- 235000011010 calcium phosphates Nutrition 0.000 claims description 4
- 239000000378 calcium silicate Substances 0.000 claims description 4
- 229910052918 calcium silicate Inorganic materials 0.000 claims description 4
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims description 4
- 239000003575 carbonaceous material Substances 0.000 claims description 4
- 210000001612 chondrocyte Anatomy 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 150000004767 nitrides Chemical class 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 239000004065 semiconductor Substances 0.000 claims description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- 229920000954 Polyglycolide Polymers 0.000 claims description 2
- 229920001710 Polyorthoester Polymers 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229930003836 cresol Natural products 0.000 claims description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 2
- 210000002242 embryoid body Anatomy 0.000 claims description 2
- 210000002889 endothelial cell Anatomy 0.000 claims description 2
- 210000001339 epidermal cell Anatomy 0.000 claims description 2
- 210000002919 epithelial cell Anatomy 0.000 claims description 2
- 210000002950 fibroblast Anatomy 0.000 claims description 2
- 238000012637 gene transfection Methods 0.000 claims description 2
- 210000004524 haematopoietic cell Anatomy 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 229940055577 oleyl alcohol Drugs 0.000 claims description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 2
- 210000000963 osteoblast Anatomy 0.000 claims description 2
- 210000004409 osteocyte Anatomy 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 229920000117 poly(dioxanone) Polymers 0.000 claims description 2
- 229920001693 poly(ether-ester) Polymers 0.000 claims description 2
- 239000002745 poly(ortho ester) Substances 0.000 claims description 2
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 108091033319 polynucleotide Proteins 0.000 claims description 2
- 102000040430 polynucleotide Human genes 0.000 claims description 2
- 239000002157 polynucleotide Substances 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 150000003384 small molecules Chemical class 0.000 claims description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 2
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 210000003594 spinal ganglia Anatomy 0.000 claims description 2
- 210000000130 stem cell Anatomy 0.000 claims description 2
- 239000010415 colloidal nanoparticle Substances 0.000 claims 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 62
- 239000000084 colloidal system Substances 0.000 description 25
- 239000008346 aqueous phase Substances 0.000 description 22
- 230000008569 process Effects 0.000 description 18
- 239000012071 phase Substances 0.000 description 16
- 238000009987 spinning Methods 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 238000001000 micrograph Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 6
- 230000005686 electrostatic field Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005204 segregation Methods 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002121 nanofiber Substances 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000005421 electrostatic potential Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
- D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/24—Formation of filaments, threads, or the like with a hollow structure; Spinnerette packs therefor
- D01D5/247—Discontinuous hollow structure or microporous structure
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
- D01F6/50—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polyalcohols, polyacetals or polyketals
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/58—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
- D01F6/62—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
- D01F6/625—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters derived from hydroxy-carboxylic acids, e.g. lactones
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
- D01F6/92—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of polyesters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2913—Rod, strand, filament or fiber
- Y10T428/2933—Coated or with bond, impregnation or core
Definitions
- This invention relates to a process of making a fiber and more particularly to ways of modifying the fiber's morphology.
- Electrospinning is an atomization process of a conducting fluid which exploits the interactions between an electrostatic field and the conducting fluid.
- ES Electrospinning
- fibers with micron or sub-micron sized diameters are extruded by means of an electrostatic potential from a polymer solution (see U.S. Pat. No. 1,975,504 to Formhals).
- a conducting fluid e.g., a semi-dilute polymer solution or a polymer melt
- a suspended conical droplet is formed, whereby the surface tension of the droplet is in equilibrium with the electric field.
- Electrostatic atomization occurs when the electrostatic field is strong enough to overcome the surface tension of the liquid.
- the liquid droplet then becomes unstable and a tiny jet is ejected from the surface of the droplet.
- the material can be collected as an interconnected web containing relatively fine, i.e. small diameter, fibers.
- the resulting films (or membranes) from these small diameter fibers have very large surface area to volume ratios and small pore sizes. This process typically yields non-woven mats or felts composed of round fibers that are extremely pliable. Due to their high- surface area and good mechanical characteristics, electrospun meshes have traditionally found applications in filtration and composite reinforcement.
- felts and meshes derived from biocompatible polymers such as poly(lactic acid) and its copolymer with glycolic acid and other polyesters are being explored as substrates (scaffolds) for association of cells in the engineering of tissue (see Kenawy et al., Biomaterials , 2003, 24(6), 907 describing making a fiber by electrospinning process from a single-phase system containing ethylene vinyl alcohol, 70% propanol and 30% water).
- Such pliable porous media is particularly suited for engineering of skin, vascular and neural prostheses.
- ES process is not amenable to significant modifications. Parameters that can be varied in the ES process are the electric field, the distance between the “Taylor Cone” and the target, and polymer solution viscosity (Fridrikh et al., G.C. Phys Rev Lett . 2003, 90(14), 144502). Due to the complexity of the fiber forming process, very few attempts have been made to alter geometry of electrospun fibers.
- U.S. Pat. No. 4,323,525 to Bornat is directed to a process for the production of tubular products by electrostatically spinning a liquid containing a fiber-forming material.
- the process involves introducing the liquid into an electric field through a nozzle, under conditions to produce fibers from a fiber-forming material, which tends to be drawn to a charged collector, and collecting the fibers on a charged tubular collector, which rotates about its longitudinal axis to form a fiberous tubular product.
- the spinning process of the '525 patent is used to fabricate tubular products having a homogenous fiber matrix across the wall thickness.
- U.S. Pat. No. 4,689,186 to Bornat is directed to a process for making polyurethane tubular products by electrostatically spinning a fiber-forming solution containing polyurethane.
- the electrospinning process of the '186 patent is used to fabricate tubular products having a homogenous fiber matrix.
- the present invention provides a method of making a fiber comprising providing a first component including water, wherein the first component has a first evaporation rate, providing a second component including a polymer dissolved in a solvent, wherein the second component has a second evaporation rate, provided that the second evaporation rate is higher than the first evaporation rate, combining the first component and the second component to make an emulsion, applying a force to the emulsion, and extruding the emulsion to make the fiber, wherein the fiber has an outer surface, an internal cavity and an outer diameter of at most 10 micrometers.
- a fiber made from the emulsion comprising water, poly(lactic acid), and optionally a nanoparticle comprising silicone oxide and a biomolecule.
- the diameter of the fiber is from about 3 nm to 10 micrometers.
- the invention provides an improvement to the known methods of making a fiber by electrospinning, wherein a fiber is formed by extruding a fiber-forming medium, such as a polymeric composition, from a vessel through an orifice under the influence of a force.
- the fiber-forming medium comprises an emulsion comprising (1) a first component comprising water, said first component is provided in an amount of at most 20 vol. %, and (2) a second component comprising a polymer, said second component is provided in an amount of at least 80 vol. %, on a condition that the first component has a first evaporation rate and the second component has a second evaporation rate and wherein the second evaporation rate is higher than the first evaporation rate.
- FIG. 1 is a graph illustrating poly(lactic acid) (PLA) fiber diameter and morphology as a function of volume fraction of aqueous phase in a water/oil (W/O) emulsion.
- FIG. 2 is an electronic microscope image of PLA fibers obtained by spinning from a single-phase system composed of PLA, chloroform and 1-methyl-2-pyrrolidinone (NMP).
- FIG. 3 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 2.5 v/v % aqueous phase; the porous nature of the fibers is shown in the inset on the bottom left.
- FIG. 4 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 14 v/v % aqueous phase.
- FIG. 5 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 885 ⁇ l PLA, 27 ⁇ l NMP, 0 ⁇ PVA(10%) and 100 ⁇ l colloid (sample E4).
- FIG. 6 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 835 ⁇ l PLA, 25 ⁇ l NMP, 50 ⁇ l PVA, and 100 ⁇ l Colloid/Water (sample E2).
- FIG. 7 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 835 ⁇ l PLA, 25 ⁇ l NMP, 50 ⁇ l PVA, and 100 ⁇ l Colloid/Water (sample E2).
- FIG. 8 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 980 ⁇ l PLA, 80 ⁇ l NMP, 2.5 ⁇ l PVA and 2.5 ⁇ l Colloid/Water (sample WC4).
- FIG. 9 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 1 g of Alginate Beads suspended in about 2 ml E4 sample and 125 ⁇ l Colloid/Water (sample AB8).
- FIG. 10 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 1 g of Alginate Beads suspended in about 2 ml E4 sample and 125 ⁇ l Colloid/Water (sample AB8).
- fiber morphology can be varied by spinning from a multiphasic fiber-forming medium such as, for example, an emulsion, rather than from a solution or a dispersion.
- a multiphasic fiber-forming medium such as, for example, an emulsion
- morphology of the resulting fiber can be controlled, wherein a preferential evaporation of the more volatile solvent causes the formation of outer surfaces or skins similar to those produced in, for example, a sausage casing process, where the less volatile liquid phase is entrapped and surrounded by a solidified polymer skin.
- the invention provides a method for making fibers of different morphologies, including, for example, flattened and porous forms.
- the ability to control morphology of the fiber is useful in various medical application such as, for example, tissue engineering, drug delivery, as well as non-medical application such as, for example, electronics.
- Another unexpected benefit ofthis invention is that due to the addition of aqueous phase, resulting fibers can be produced with smaller diameters, as compared to the fibers produced from a single-phase solution of identical polymer concentration.
- the present invention provides a method of making a fiber from an emulsion comprising a first component including water, and a second component including a polymer dissolved in a solvent.
- a force is applied to the emulsion to extrude and separate the emulsion into a fiber, wherein the fiber has an outer surface, an internal cavity and an outer diameter of at most 10 micrometers.
- the force is preferably created by an electrostatic field, i.e., an electric force.
- the emulsion is preferably electrically conductive or includes electrically conductive materials.
- Other examples of the force include a magnetic force and an electromagnetic force. Another non-limiting example of the force is a force of pressurized gas.
- Apparatuses useful in this invention for creation of the electrostatic field are Known in the art such as, for example, electrospinners described by Fridrikh et al. and Bornat supra.
- the technique of spinning liquids has been described in the art, for example, in U.S. Pat. No. 4,044,404.
- These apparatuses employ the electric force for spinning the multiphasic fiber-forming medium of the invention.
- Another type of apparatuses employs a compressed gas as described by U.S. Pat. No. 6,520,425 by Reneker.
- the multiphasic fiber-forming medium of the invention is an emulsion, such as, for example, a water/oil emulsion, a double emulsion or an emulsion in which particles are dispersed.
- a emulsion such as, for example, a water/oil emulsion, a double emulsion or an emulsion in which particles are dispersed.
- the first component an aqueous phase or a hydrophilic component
- the second component an oil phase or a lipophilic component
- has a second evaporation rate such that the second evaporation rate is higher than the first evaporation rate.
- the first component comprises water and optionally, glycerol and poly(vinyl alcohol). In certain embodiments, the first component comprises at most 20 vol. % of the emulsion. In certain embodiments, the first component comprises from about 5 to about 20 vol. %. In certain embodiments, the first component comprises from about 2 to 5 vol. %.
- the organic solvent is a member selected from the group consisting of methylene chloride, chloroform, ether, hexane, pentane, petroleum ether, cresol, dichloroethane, ethyl acetate, methyl ethyl ketone, dioxane, propylene carbonate, and butyl acetate.
- emulsion Various additives can be added to the emulsion, such as, for example, a surfactant, an emulsifier, and a stabilizer for impacting properties of emulsion such as stability, consistency, etc.
- a surfactant such as sodium sulfate
- an emulsifier such as sodium sulfate
- a stabilizer for impacting properties of emulsion such as stability, consistency, etc.
- the emulsion can be a microemulsion.
- the emulsion comprises a third component such as, for example, a biomolecule, a cell, a particle, and a gel.
- the third component can be dissolved in either or both of the phases or it can be dispersed. Depending on the choice of the phase, the third component can be located inside or outside of the fiber. For example, if the third component is dissolved in the aqueous phase, upon forming of the fiber, it will be trapped inside, upon evaporation of the solvent of the second phase. Also, if the third component is dissolved in the second phase, upon forming of the fiber, it will be trapped in the outer skin of the fiber.
- Non-limiting examples of suitable biomolecules include a bioactive polypeptide, a polynucleotide coding for the bioactive polypeptide, a cell regulatory small molecule, a peptide, a protein, an oligonucleotide, a nucleic acid, a poly(saccharide), an adenoviral vector, a gene transfection vector, a drug, and a drug delivering agent.
- Non-limiting examples of suitable cells include chondroblast, chondrocyte, fibroblast, an endothelial cell, osteoblast, osteocyte, an epithelial cell, an epidermal cell, a mesenchymal cell, a hemopoietic cell, an embryoid body, a stem cell, and dorsal root ganglia.
- the particle is a colloidal particle or a solid particle. Patterning the surfaces of fibers with particles has practical applications, for example, in tissue engineering where presentation of chemical and physical cues on degradable scaffolds allows a more precise control over cell-scaffold interactions.
- the colloidal particle has a diamneter of from about 3 nm to about 10 micrometers and includes a polymer, an oxide, a nitride, a carbide, calcium silicate, calcium phosphate, calcium carbonate, a carbonaceous material, a metal, and a semiconductor.
- the solid particle has a diameter of about 3 nm to about 10 micrometers and said solid nanoparticle is a member selected from the group consisting of a polymer, an oxide, a nitride, a carbide, calcium silicate, calcium phosphate, calcium carbonate, a carbonaceous material, a metal, and a semiconductor.
- SNP encapsulation silica nanoparticles
- Non-limiting examples of surfactants include non-ionic surfactants such as, for example, PLURONIC, polyvinyl alcohol, poly(sorbate) (such as, for example, TWEEN-80 and SPAN-20), oleyl alcohol, glycerol ester, sorbitol, and carboxy methoxy cellulose or an ionic surfactant such as, for example, sodium dodecyl sulfonate, sodium dodecyl benzene sulfonate, oleic acid, albumin, ova-albumin, lecithin, natural lipids, and synthetic lipids.
- non-ionic surfactants such as, for example, PLURONIC, polyvinyl alcohol, poly(sorbate) (such as, for example, TWEEN-80 and SPAN-20), oleyl alcohol, glycerol ester, sorbitol, and carboxy methoxy cellulose or an ionic surfactant such as, for example, sodium dodecyl
- the emulsion comprises water mixed with poly(vinyl alcohol) as the first components and poly(lactic acid) dissolved in organic solvent as the second component, and optionally, silicone oxide nanoparticle having a biomolecule-attached to the nanopatricle's surface as the third component.
- the invention also provides a fiber manufactured by the method of the invention as described above, wherein the morphology of the fiber is controlled by varying a ratio of the first component to the second component.
- a non-limiting example of the desired fiber is a fiber made from the emulsion comprising water, poly(lactic acid), and optionally a nanoparticle comprising silicone oxide and a biomolecule.
- the diameter of the fiber is from about 3 nm to 10 micrometers.
- the invention provides an improvement to the known methods of making a fiber by electrospinning, wherein a fiber is formed by extruding a fiber-forming medium, such as a polymeric composition, from a vessel through an orifice under the influence of a force.
- the fiber-forming medium comprises an emulsion comprising (1) a first component comprising water, said first component is provided in an amount of at most 20 vol. %, and (2) a second component comprising a polymer, said second component is provided in an amount of at least 80 vol. %, on a condition that the first component has a first evaporation rate and the second component has a second evaporation rate and wherein the second evaporation rate is higher than the first evaporation rate.
- the invention will be described based on the effect of a water/oil emulsion on the morphology of poly(L-lactic acid) (PLA) fibers obtained by ES.
- Chloroform (HPLC grade, 99.8%) was purchased from Fisher Scientific (Pittsburgh, Pa.).
- Poly(acrylic acid) coated Silica colloids 500 nm in diameter were produced by a sol-gel process. All chemicals were used as received without further purification unless otherwise noted.
- the polymer solution typically volume 1 ml
- the syringe was mounted on a ring stand at a 45° angle below horizontal.
- the needle was connected to a high voltage power supply (Gamma High Voltage Research, Ormond Beach, Fla.).
- the counter electrode was connected to an aluminum foil (collecting target) placed at a distance of 15 cm away from the tip of the needle. The bias between each plate was then slowly increased until the eruption of the “Taylor Cone” and was then set at 25 kV. Fibers were collected on the aluminum foil until the solution was fully dispensed.
- Electrospun fibers were imaged using a JEOL 6300FV field emission scanning electron microscope at an acceleration voltage of 10 KeV (see FIGS. 2-9 ). Samples were mounted onto aluminum stubs using conductive carbon tape and then sputter coated with Pd-C to minimize charging. TIFF files of the images were then imported into Scion Image (NIH, Bethesda, Md.) for analysis.
- W/O emulsions of PLA dissolved in a chloroform/NMP mixture and water, stabilized by PVA were used as a model two-phase system to study its effect on fiber morphology in the ES process.
- the choice of this system was driven by two considerations, namely, easy adaptability to biomedical applications and biocompatibility of the non-volatile components. Solutions containing up to 15% aqueous phase were successfully electrospun without any disruption of the fiber morphology. However, solutions that contained greater than 20% by volume of aqueous phase tended to spray as droplets suggesting the onset of instability of the “Taylor Cone”.
- the typical fiber morphology obtained in the ES process is that of a circular rod ( FIG. 2 ).
- fiber morphology can be varied from round spaghetti-like, to porous ( FIG. 3 ), to flat ribbon-like fibers ( FIG. 4 ) without varying the conditions of the ES process, namely the bias lent by selecting appropriate emulsion compositions.
- SEM analyses of the fibers reveal that the transition from round to porous fibers occurs in the range of 2-5% volume fraction of aqueous phase in the emulsion. Above 5% volume fraction of aqueous phase, fibers with a flat-ribbon morphology are obtained. This transition may be explained as follows.
- the emulsion droplets are relatively stable and there is no further segregation for the entire duration of the ES process.
- the polymer fraction which constitutes the vast majority undergoes solidification due to the evaporation of the volatile organic phase (chloroform) and the resulting fiber stretches as it approaches the target, while the aqueous phase remains entrapped within the rapidly solidifying polymer (oil) phase.
- the aqueous droplets become regions of instability toward the later stage of solidification as it constitutes a larger portion of the liquid phase, and a surface tension driven phase segregation process can result yielding porous fibers upon the evaporation of the aqueous component.
- the stability of the emulsion is rather poor even at the early stage of ES and solidification and this leads to rapid phase segregation and the encapsulation of larger water droplets within the solidifying polymer phase.
- the aqueous phase coalesce to yield a structure similar to a water filled balloon or a garden hose.
- the polymer skin eventually collapses, probably after partial evaporation of the entrapped aqueous phase, because of buckling instability in bending a thin wall tube. This yields fibers with flat, ribbon-like morphologies. This mechanism has also been verified through indirect observations in systems containing silica colloids.
Abstract
The invention provides a fiber having different morphology and a method of making such fiber in a predictable manner. The method includes providing a first component including water, wherein the first component has a first evaporation rate, providing a second component including a polymer, wherein the second component has a second evaporation rate, provided that the second evaporation rate is higher than the first evaporation rate, combining the first component and the second component to make an emulsion, applying a force to the emulsion, and extruding the emulsion to make the fiber, wherein the fiber has an outer surface, an internal cavity and a diameter of at most 10 micrometers.
Description
- This application claims the benefit of provisional Application No. 60/556,637, filed on Mar. 25, 2004, which is incorporated herein in its entirety.
- This research was supported in part by U.S. Government funds (National Institute of Health, grant number R24-AI47739-03), and the U.S. Government may therefore have certain rights in the invention.
- 1. Field of Invention
- This invention relates to a process of making a fiber and more particularly to ways of modifying the fiber's morphology.
- 2. Description of Related Art
- Electrospinning (ES) is an atomization process of a conducting fluid which exploits the interactions between an electrostatic field and the conducting fluid. During electrospinning, fibers with micron or sub-micron sized diameters are extruded by means of an electrostatic potential from a polymer solution (see U.S. Pat. No. 1,975,504 to Formhals). When an external electrostatic field is applied to a conducting fluid (e.g., a semi-dilute polymer solution or a polymer melt), a suspended conical droplet is formed, whereby the surface tension of the droplet is in equilibrium with the electric field. Electrostatic atomization occurs when the electrostatic field is strong enough to overcome the surface tension of the liquid. The liquid droplet then becomes unstable and a tiny jet is ejected from the surface of the droplet. As it reaches a grounded target, the material can be collected as an interconnected web containing relatively fine, i.e. small diameter, fibers. The resulting films (or membranes) from these small diameter fibers have very large surface area to volume ratios and small pore sizes. This process typically yields non-woven mats or felts composed of round fibers that are extremely pliable. Due to their high- surface area and good mechanical characteristics, electrospun meshes have traditionally found applications in filtration and composite reinforcement. For the very same reasons, felts and meshes derived from biocompatible polymers such as poly(lactic acid) and its copolymer with glycolic acid and other polyesters are being explored as substrates (scaffolds) for association of cells in the engineering of tissue (see Kenawy et al., Biomaterials, 2003, 24(6), 907 describing making a fiber by electrospinning process from a single-phase system containing ethylene vinyl alcohol, 70% propanol and 30% water). Such pliable porous media is particularly suited for engineering of skin, vascular and neural prostheses.
- Electrospun materials possess a high aspect ratio to allow for cell attachment and spreading, which is a desired property for tissue engineering (TE) applications. The longest axis of a spread cell is typically around 5-10 micrometers. ES process is not amenable to significant modifications. Parameters that can be varied in the ES process are the electric field, the distance between the “Taylor Cone” and the target, and polymer solution viscosity (Fridrikh et al., G.C. Phys Rev Lett. 2003, 90(14), 144502). Due to the complexity of the fiber forming process, very few attempts have been made to alter geometry of electrospun fibers. Recently, Reneker and co- workers have observed the formation of branched and ribbon-like fibers in some solvent systems and have attributed this to the collapse of a polymer skin due to buckling instability similar to that seen in garden hoses (see Koombhongse et al., Polym. Sci.: Part B: Polyrn. Phys. 2001, 39, 2598-2606). However, the formation of such fibers is not achievable in a predictable manner under generally known ES operating conditions.
- U.S. Pat. No. 4,323,525 to Bornat is directed to a process for the production of tubular products by electrostatically spinning a liquid containing a fiber-forming material. The process involves introducing the liquid into an electric field through a nozzle, under conditions to produce fibers from a fiber-forming material, which tends to be drawn to a charged collector, and collecting the fibers on a charged tubular collector, which rotates about its longitudinal axis to form a fiberous tubular product. However, there is no suggestion or teaching of how to control the physical characteristics of the tubular product, other than by controlling the charge and rotation speed of the tubular collector. The spinning process of the '525 patent is used to fabricate tubular products having a homogenous fiber matrix across the wall thickness.
- U.S. Pat. No. 4,689,186 to Bornat is directed to a process for making polyurethane tubular products by electrostatically spinning a fiber-forming solution containing polyurethane. The electrospinning process of the '186 patent is used to fabricate tubular products having a homogenous fiber matrix.
- Sanders et al. describe entrapment of water droplets in polyvinyl acetate fibers spun from a suspension containing a polymer in methylene chloride and protein (BSA) in a phosphate buffer. The fiber-forming composition was a cloudy suspension and not an emulsion. The ratio of organic solvent to water is 40:1 or about 2.4 vol %. There was no emulsifying agent used in the fiber-forming composition (see Macromolecules 2003, 36, 3803-3805).
- There are methods other than electrospinning for creation nanofibers. For example, U.S. Pat. No. 6,520,425 to Reneker describes forming nanofibers by using a pressurized gas stream to overcome problems associated with liquids having higher viscosities and inability to create higher forces than electric fields can supply.
- Despite the foregoing development, it is desired to provide a method of making fibers with desirable morphology in a predictable and controllable manner.
- All references cited herein are incorporated herein by reference in their entireties.
- Inventors have discovered that fiber morphology can be controlled by using multiphasic compositions, such as, for example, a water/oil emulsion or a double emulsion as a fiber-forming medium. The present invention provides a method of making a fiber comprising providing a first component including water, wherein the first component has a first evaporation rate, providing a second component including a polymer dissolved in a solvent, wherein the second component has a second evaporation rate, provided that the second evaporation rate is higher than the first evaporation rate, combining the first component and the second component to make an emulsion, applying a force to the emulsion, and extruding the emulsion to make the fiber, wherein the fiber has an outer surface, an internal cavity and an outer diameter of at most 10 micrometers.
- Also provided is a fiber manufactured by the method of the invention.
- Further provided is a fiber made from the emulsion comprising water, poly(lactic acid), and optionally a nanoparticle comprising silicone oxide and a biomolecule. In certain embodiments, the diameter of the fiber is from about 3 nm to 10 micrometers.
- Also the invention provides an improvement to the known methods of making a fiber by electrospinning, wherein a fiber is formed by extruding a fiber-forming medium, such as a polymeric composition, from a vessel through an orifice under the influence of a force. In the improvement, the fiber-forming medium comprises an emulsion comprising (1) a first component comprising water, said first component is provided in an amount of at most 20 vol. %, and (2) a second component comprising a polymer, said second component is provided in an amount of at least 80 vol. %, on a condition that the first component has a first evaporation rate and the second component has a second evaporation rate and wherein the second evaporation rate is higher than the first evaporation rate.
- The invention will be described in conjunction with the following drawings in which like reference numerals designate like elements and wherein:
-
FIG. 1 is a graph illustrating poly(lactic acid) (PLA) fiber diameter and morphology as a function of volume fraction of aqueous phase in a water/oil (W/O) emulsion. -
FIG. 2 is an electronic microscope image of PLA fibers obtained by spinning from a single-phase system composed of PLA, chloroform and 1-methyl-2-pyrrolidinone (NMP). -
FIG. 3 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 2.5 v/v % aqueous phase; the porous nature of the fibers is shown in the inset on the bottom left. -
FIG. 4 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 14 v/v % aqueous phase. -
FIG. 5 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 885 μl PLA, 27 μl NMP, 0 μPVA(10%) and 100 μl colloid (sample E4). -
FIG. 6 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 835 μl PLA, 25 μl NMP, 50 μl PVA, and 100 μl Colloid/Water (sample E2). -
FIG. 7 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 835 μl PLA, 25 μl NMP, 50 μl PVA, and 100 μl Colloid/Water (sample E2). -
FIG. 8 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 980 μl PLA, 80 μl NMP, 2.5 μl PVA and 2.5 μl Colloid/Water (sample WC4). -
FIG. 9 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 1 g of Alginate Beads suspended in about 2 ml E4 sample and 125 μl Colloid/Water (sample AB8). -
FIG. 10 is an electronic microscope image of PLA fibers obtained by spinning from a W/O emulsion composed of 1 g of Alginate Beads suspended in about 2 ml E4 sample and 125 μl Colloid/Water (sample AB8). - Inventors have discovered that that fiber morphology can be varied by spinning from a multiphasic fiber-forming medium such as, for example, an emulsion, rather than from a solution or a dispersion. Advantageously, by using at least two-solvent systems having varying evaporation rates and miscibility, morphology of the resulting fiber can be controlled, wherein a preferential evaporation of the more volatile solvent causes the formation of outer surfaces or skins similar to those produced in, for example, a sausage casing process, where the less volatile liquid phase is entrapped and surrounded by a solidified polymer skin. Thus, the invention provides a method for making fibers of different morphologies, including, for example, flattened and porous forms. The ability to control morphology of the fiber is useful in various medical application such as, for example, tissue engineering, drug delivery, as well as non-medical application such as, for example, electronics. Another unexpected benefit ofthis invention is that due to the addition of aqueous phase, resulting fibers can be produced with smaller diameters, as compared to the fibers produced from a single-phase solution of identical polymer concentration.
- Accordingly, the present invention provides a method of making a fiber from an emulsion comprising a first component including water, and a second component including a polymer dissolved in a solvent. In the method, a force is applied to the emulsion to extrude and separate the emulsion into a fiber, wherein the fiber has an outer surface, an internal cavity and an outer diameter of at most 10 micrometers. The force is preferably created by an electrostatic field, i.e., an electric force. In this example, the emulsion is preferably electrically conductive or includes electrically conductive materials. Other examples of the force include a magnetic force and an electromagnetic force. Another non-limiting example of the force is a force of pressurized gas.
- Apparatuses useful in this invention for creation of the electrostatic field are Known in the art such as, for example, electrospinners described by Fridrikh et al. and Bornat supra. The technique of spinning liquids has been described in the art, for example, in U.S. Pat. No. 4,044,404. These apparatuses employ the electric force for spinning the multiphasic fiber-forming medium of the invention. Another type of apparatuses employs a compressed gas as described by U.S. Pat. No. 6,520,425 by Reneker.
- The multiphasic fiber-forming medium of the invention is an emulsion, such as, for example, a water/oil emulsion, a double emulsion or an emulsion in which particles are dispersed. In forming the emulsion, at least two components are mixed, wherein the first component (an aqueous phase or a hydrophilic component) has a first evaporation rate, and the second component (an oil phase or a lipophilic component) has a second evaporation rate, such that the second evaporation rate is higher than the first evaporation rate.
- By varying the ratio of components in the emulsion, desired morphology can be achieved as described below. In certain embodiments, the fist component and the second component are provided at a ratio, wherein the ratio is adapted to change morphology of the fiber and its diameter. Examples of fibers with various morphologies include flat fiber, round fiber, porous fiber and combinations thereof (see
FIGS. 2-9 ). It was observed for an exemplary PLA emulsion, the transition from round to porous fibers occurs in the range of 2-5% volume fraction of aqueous phase in the emulsion. Above 5% volume fraction of aqueous phase, fibers with a flat-ribbon morphology are obtained. - In certain embodiments, the first component comprises water and optionally, glycerol and poly(vinyl alcohol). In certain embodiments, the first component comprises at most 20 vol. % of the emulsion. In certain embodiments, the first component comprises from about 5 to about 20 vol. %. In certain embodiments, the first component comprises from about 2 to 5 vol. %.
- In certain embodiments, the second component comprises at least 80% of the emulsion. In certain embodiments, the second component comprises polymer, preferably dissolved in an organic solvent. Non-limiting examples of suitable polymers include poly(styrene), poly(urethane), poly(lactic acid), poly(glycolic acid), poly(ester), poly(alpha-hydroxy acid), poly(ε-caprolactone), poly(dioxanone), poly(orthoester), poly(ether-ester), poly(lactone), poly(carbonate), poly(phosphazene), poly(phosphanate), poly(ether), poly(anhydride), mixtures thereof and copolymers thereof.
- In certain embodiments, the organic solvent is a member selected from the group consisting of methylene chloride, chloroform, ether, hexane, pentane, petroleum ether, cresol, dichloroethane, ethyl acetate, methyl ethyl ketone, dioxane, propylene carbonate, and butyl acetate.
- Various additives can be added to the emulsion, such as, for example, a surfactant, an emulsifier, and a stabilizer for impacting properties of emulsion such as stability, consistency, etc. Depending on ratios of first component to the second component, the emulsion can be a microemulsion.
- In certain embodiments, the emulsion comprises a third component such as, for example, a biomolecule, a cell, a particle, and a gel. The third component can be dissolved in either or both of the phases or it can be dispersed. Depending on the choice of the phase, the third component can be located inside or outside of the fiber. For example, if the third component is dissolved in the aqueous phase, upon forming of the fiber, it will be trapped inside, upon evaporation of the solvent of the second phase. Also, if the third component is dissolved in the second phase, upon forming of the fiber, it will be trapped in the outer skin of the fiber.
- Non-limiting examples of suitable biomolecules include a bioactive polypeptide, a polynucleotide coding for the bioactive polypeptide, a cell regulatory small molecule, a peptide, a protein, an oligonucleotide, a nucleic acid, a poly(saccharide), an adenoviral vector, a gene transfection vector, a drug, and a drug delivering agent.
- Non-limiting examples of suitable cells include chondroblast, chondrocyte, fibroblast, an endothelial cell, osteoblast, osteocyte, an epithelial cell, an epidermal cell, a mesenchymal cell, a hemopoietic cell, an embryoid body, a stem cell, and dorsal root ganglia.
- In certain embodiments, the particle is a colloidal particle or a solid particle. Patterning the surfaces of fibers with particles has practical applications, for example, in tissue engineering where presentation of chemical and physical cues on degradable scaffolds allows a more precise control over cell-scaffold interactions.
- In certain embodiments, the colloidal particle has a diamneter of from about 3 nm to about 10 micrometers and includes a polymer, an oxide, a nitride, a carbide, calcium silicate, calcium phosphate, calcium carbonate, a carbonaceous material, a metal, and a semiconductor.
- In certain embodiments, the solid particle has a diameter of about 3 nm to about 10 micrometers and said solid nanoparticle is a member selected from the group consisting of a polymer, an oxide, a nitride, a carbide, calcium silicate, calcium phosphate, calcium carbonate, a carbonaceous material, a metal, and a semiconductor.
- An example of incorporation of solid particles is encapsulation silica nanoparticles (SNP) within polymeric fibers. The presence of SNP within the fibers was verified using SEM and BET measurements, which revealed the presence of a phase with a very high surface area (>50 m2/gm). Also, carbon nanotubes and magnetic particles are examples of solid particles suitable in this invention.
- Non-limiting examples of surfactants include non-ionic surfactants such as, for example, PLURONIC, polyvinyl alcohol, poly(sorbate) (such as, for example, TWEEN-80 and SPAN-20), oleyl alcohol, glycerol ester, sorbitol, and carboxy methoxy cellulose or an ionic surfactant such as, for example, sodium dodecyl sulfonate, sodium dodecyl benzene sulfonate, oleic acid, albumin, ova-albumin, lecithin, natural lipids, and synthetic lipids.
- In certain embodiments, the emulsion comprises water mixed with poly(vinyl alcohol) as the first components and poly(lactic acid) dissolved in organic solvent as the second component, and optionally, silicone oxide nanoparticle having a biomolecule-attached to the nanopatricle's surface as the third component.
- The invention also provides a fiber manufactured by the method of the invention as described above, wherein the morphology of the fiber is controlled by varying a ratio of the first component to the second component.
- A non-limiting example of the desired fiber is a fiber made from the emulsion comprising water, poly(lactic acid), and optionally a nanoparticle comprising silicone oxide and a biomolecule. In certain embodiments, the diameter of the fiber is from about 3 nm to 10 micrometers.
- Also the invention provides an improvement to the known methods of making a fiber by electrospinning, wherein a fiber is formed by extruding a fiber-forming medium, such as a polymeric composition, from a vessel through an orifice under the influence of a force. In the improvement, the fiber-forming medium comprises an emulsion comprising (1) a first component comprising water, said first component is provided in an amount of at most 20 vol. %, and (2) a second component comprising a polymer, said second component is provided in an amount of at least 80 vol. %, on a condition that the first component has a first evaporation rate and the second component has a second evaporation rate and wherein the second evaporation rate is higher than the first evaporation rate.
- The invention will be illustrated in more detail with reference to the following Examples, but it should be understood that the present invention is not deemed to be limited thereto.
- As a non-limiting example, the invention will be described based on the effect of a water/oil emulsion on the morphology of poly(L-lactic acid) (PLA) fibers obtained by ES.
- Materials: Poly(L-lactic acid) (MW=300,000) (PLA) was purchased from Polysciences, Inc. (Warrington, PA). Poly(vinyl alcohol) (MW=10,000, 85% hydrolyzed) (PVA) and 1-methyl-2-pyrrolidinone (99.5%) (NMP) were purchased from Aldrich Chemical Co (Milwaukee, Wis.). Chloroform (HPLC grade, 99.8%) was purchased from Fisher Scientific (Pittsburgh, Pa.). Poly(acrylic acid) coated Silica colloids 500 nm in diameter were produced by a sol-gel process. All chemicals were used as received without further purification unless otherwise noted.
- Preparation of Polymer Solutions. Water-in-oil (W/O) emulsion of PLA was prepared by emulsifying a 2% stock of PLA in chloroform with 5% PVA solution in water and a fixed volume of NMP (Table 1). NMP was added to the mixture to serve as a phase compatibilizer (NMP is soluble in both water and chloroform) and to retard the evaporation of chloroform (oil phase). Formulations containing varying amounts of aqueous phase and PVA and PLA were studied and are shown in Table 1. To aid in the analysis of the evolution of fiber morphology and get an insight into the mechanism of fiber formation, silica colloids (<1% v/v) were added to some of the formulations. All components were metered using an Eppendorf pipette, mixed by vortexing and sonicated for 45 seconds (20 KHz, Vibra Cell, Sonic Systems) to ensure full emulsification.
TABLE 1 Description of Composition of Samples Sample Composition C1 990 μl PLA 30 μl NMP C2 885 μl PLA 27 μl NMP 50 μl PVA 50 μl Water C3 885 μl Chloroform 27 μl NMP 50 μl PLA 50 μl Water E1 885 μl PLA 27 μl NMP 50 μl PVA 50 μl Colloid/Water E2 835 μl PLA 25 μl NMP 50 μl PVA 100 μl Colloid/Water E3 905 μl PLA 27 μl NMP 50 μl PVA 25 μl Colloid/Water E4 885 μl PLA 27 μl NMP 10 μl PVA(10%) 100 μl Colloid EL4 885 μl PLA 27 μl NMP 10 μl PVA(10%) 100 μl Ludox Colloid V1 885 μl PLA 27 μl NMP 50 μl PVA (2.5%) 50 μl Colloid/Water V2 885 μl PLA 27 μl NMP 50 μl PVA (1%) 50 μl Colloid/Water V3 885 μl PLA 27 μl NMP 50 μl PVA (0.5%) 50 μl Colloid/Water AB8 Alginate Beads suspended in ˜2 ml of E4 solution 125 μl Colloid/Water WC1 935 μl PLA 29 μl NMP 25 μl PVA 25 μl Colloid/Water WC2 960 μl PLA 29 μl NMP 12.5 μl PVA 12.5 Colloid/Water WC3 975 μl PLA 30 μl NMP 5 μl PVA 5 μl Colloid/Water WC4 980 μl PLA 80 μl NMP 2.5 μl PVA 2.5 μl Colloid/Water WC5 485 μl PLA 15 μl NMP 250 μl PVA 250 μl Colloid/Water WC6 730 μl PLA 23 μl NMP 125 μl PVA WC7 830 μl PLA 26 μl NMP 75 μl PVA 75 μl Colloid/Water WC8 785 μl PLA 24 μl NMP 100 μl PVA 100 μl Colloid/Water - Electrospinning of PLA fibers. The polymer solution (
typical volume 1 ml) was loaded into a 3 ml syringe fitted with a 16-gauge blunt tip needle. The syringe was mounted on a ring stand at a 45° angle below horizontal. The needle was connected to a high voltage power supply (Gamma High Voltage Research, Ormond Beach, Fla.). The counter electrode was connected to an aluminum foil (collecting target) placed at a distance of 15 cm away from the tip of the needle. The bias between each plate was then slowly increased until the eruption of the “Taylor Cone” and was then set at 25 kV. Fibers were collected on the aluminum foil until the solution was fully dispensed. - Electrospun fibers were imaged using a JEOL 6300FV field emission scanning electron microscope at an acceleration voltage of 10 KeV (see
FIGS. 2-9 ). Samples were mounted onto aluminum stubs using conductive carbon tape and then sputter coated with Pd-C to minimize charging. TIFF files of the images were then imported into Scion Image (NIH, Bethesda, Md.) for analysis. - W/O emulsions of PLA dissolved in a chloroform/NMP mixture and water, stabilized by PVA, were used as a model two-phase system to study its effect on fiber morphology in the ES process. The choice of this system was driven by two considerations, namely, easy adaptability to biomedical applications and biocompatibility of the non-volatile components. Solutions containing up to 15% aqueous phase were successfully electrospun without any disruption of the fiber morphology. However, solutions that contained greater than 20% by volume of aqueous phase tended to spray as droplets suggesting the onset of instability of the “Taylor Cone”. Inventors observed that by varying the volume fraction of the aqueous phase, the morphology and diameter of PLA fibers could be significantly impacted. In general, increasing the volume fraction of the aqueous phase yielded fibers with smaller diameters (
FIG. 1 ). One contributing factor could be the lower volume fraction of polymer at higher aqueous phase concentrations. Rheological effects are most likely the dominant component of the fiber-thinning process. However, inventors observed no correlation between PVA concentration and fiber diameter. A synergetic effect was observed, wherein an order of magnitude change in fiber diameter can be achieved with the introduction of a small volume fraction of aqueous phase. The fiber diameter data can be fitted to an exponential decay process, which is consistent with a trend one may observe with respect to the stability of emulsions. The typical fiber morphology obtained in the ES process is that of a circular rod (FIG. 2 ). However, in this invention fiber morphology can be varied from round spaghetti-like, to porous (FIG. 3 ), to flat ribbon-like fibers (FIG. 4 ) without varying the conditions of the ES process, namely the bias lent by selecting appropriate emulsion compositions. SEM analyses of the fibers reveal that the transition from round to porous fibers occurs in the range of 2-5% volume fraction of aqueous phase in the emulsion. Above 5% volume fraction of aqueous phase, fibers with a flat-ribbon morphology are obtained. This transition may be explained as follows. At lower aqueous phase volume fractions, the emulsion droplets are relatively stable and there is no further segregation for the entire duration of the ES process. As the emulsion solution is propelled towards the target the polymer fraction, which constitutes the vast majority undergoes solidification due to the evaporation of the volatile organic phase (chloroform) and the resulting fiber stretches as it approaches the target, while the aqueous phase remains entrapped within the rapidly solidifying polymer (oil) phase. The aqueous droplets become regions of instability toward the later stage of solidification as it constitutes a larger portion of the liquid phase, and a surface tension driven phase segregation process can result yielding porous fibers upon the evaporation of the aqueous component. At still higher volume fractions of aqueous phase, the stability of the emulsion is rather poor even at the early stage of ES and solidification and this leads to rapid phase segregation and the encapsulation of larger water droplets within the solidifying polymer phase. As the polymer skin evolves, the aqueous phase coalesce to yield a structure similar to a water filled balloon or a garden hose. The polymer skin eventually collapses, probably after partial evaporation of the entrapped aqueous phase, because of buckling instability in bending a thin wall tube. This yields fibers with flat, ribbon-like morphologies. This mechanism has also been verified through indirect observations in systems containing silica colloids. - While the invention has been described in detail and with reference to specific examples thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.
Claims (22)
1. A method of making a fiber, the method comprising:
providing a first component comprising water, wherein the first component has a first evaporation rate;
providing a second component comprising a polymer dissolved in a solvent, wherein the second component has a second evaporation rate, provided that the second evaporation rate is higher than the first evaporation rate;
combining the first component, the second component to make an emulsion;
applying a force to the emulsion; and
extruding the emulsion to make the fiber, wherein the fiber has an outer surface, an internal cavity and a diameter of at most 10 micrometers.
2. The method of claim 1 , wherein the first component comprises at most 20 vol. % of the emulsion.
3. The method of claim 1 , wherein the first component comprises from about 5 to about 20 vol. % of the emulsion.
4. The method of claim 1 , wherein the first component comprises from about 2 to 5 vol. % of the emulsion.
5. The method of claim 1 , wherein the second component comprises at least 80% of the emulsion.
6. The method of claim 1 , wherein the first component comprises glycerol and poly(vinyl alcohol).
7. The method of claim 1 , wherein the polymer is a member selected from the group consisting of poly(styrene), poly(urethane), poly(lactic acid), poly(glycolic acid), poly(ester), poly(alpha-hydroxy acid), poly(E-caprolactone), poly(dioxanone), poly(orthoester), poly(ether-ester), poly(lactone), poly(carbonate), poly(phosphazene), poly(phosphanate), poly(ether), poly(anhydride), mixtures thereof and copolymers thereof.
8. The method of claim 1 , wherein the solvent is a member selected from the group consisting of methylene chloride, chloroform, ether, hexane, pentane, petroleum ether, cresol, dichloroethane, ethyl acetate, methyl ethyl ketone, dioxane, propylene carbonate, and butyl acetate.
9. The method of claim 1 , further providing a third component, said third component is being a member selected from the group consisting of a biomolecule, a cell, a particle, and a gel.
10. The method of claim 9 , wherein the biomolecule is a member selected from the group consisting of a bioactive polypeptide, a polynucleotide coding for the bioactive polypeptide, a cell regulatory small molecule, a peptide, a protein, an oligonucleotide, a nucleic acid, a poly(saccharide), an adenoviral vector, a gene transfection vector, a drug, and a drug delivering agent.
11. The method of claim 9 , wherein the cell is a member selected from the group consisting of chondroblast, chondrocyte, fibroblast, an endothelial cell, osteoblast, osteocyte, an epithelial cell, an epidermal cell, a mesenchymal cell, a hemopoietic cell, an embryoid body, a stem cell, and dorsal root ganglia.
12. The method of claim 9 , wherein the particle is a colloidal particle or a solid particle.
13. The method of claim 12 , wherein the colloidal particle has a diameter of about 3 nm to about 10 micrometers and said colloidal nanoparticle is a member selected from the group consisting of a polymer, an oxide, a nitride, a carbide, calcium silicate, calcium phosphate, calcium carbonate, a carbonaceous material, a metal, and a semiconductor.
14. The method of claim 12 , wherein the solid particle has a diameter of about 3 nm to about 10 micrometers and said solid nanoparticle is a member selected from the group consisting of a polymer, an oxide, a nitride, a carbide, calcium silicate, calcium phosphate, calcium carbonate, a carbonaceous material, a metal, and a semiconductor.
15. The method of claim 9 , wherein the surfactant is a member selected from the group consisting of PLURONIC, polyvinyl alcohol, poly(sorbate), oleyl alcohol, glycerol ester, sorbitol, carboxy methoxy cellulose, sodium dodecyl sulfonate, sodium dodecyl benzene sulfonate, oleic acid, albumin, ova-albumin, lecithin, natural lipids, and synthetic lipids.
16. The method of claim 1 , wherein the emulsion comprises water, poly(lactic acid), poly(vinyl alcohol) and optionally a silicone oxide nanoparticle comprising a biomolecule.
17. The method of claim 1 , wherein the first component and the second component are provided at a ratio, wherein the ratio is adapted to affect morphology of the fiber.
18. The method of claim 17 , wherein the morphology is a member selected from the group consisting of flat fiber, round fiber, porous fiber and a combination thereof.
19. A fiber manufactured by the method of claim 1 .
20. The fiber of claim 19 , wherein the emulsion comprises water, poly(lactic acid), and optionally a nanoparticle comprising silicone oxide and the biomolecule.
21. The fiber of claim 19 , wherein the diameter is about 3 nm to 10 micrometers.
22. In a method of making a fiber by electrospinning wherein the fiber is formed by extruding a fiber-forming medium from a vessel through an orifice under influence of a force, the improvement wherein the fiber-forming medium comprises an emulsion including (1) a first component comprising water, the first component is provided in an amount of at most 20 vol. %, and (2) a second component comprising a polymer, the second component is provided in an amount of at least 80 vol. %, on a condition that the first component has a first evaporation rate and the second component has a second evaporation rate and wherein the second evaporation rate is higher than the first evaporation rate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/594,094 US20070141333A1 (en) | 2004-03-25 | 2005-03-17 | Emulsion-based control of electrospun fiber morphology |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55663704P | 2004-03-25 | 2004-03-25 | |
PCT/US2005/009048 WO2005098099A1 (en) | 2004-03-25 | 2005-03-17 | Emulsion-based control of electrospun fiber morphology |
US10/594,094 US20070141333A1 (en) | 2004-03-25 | 2005-03-17 | Emulsion-based control of electrospun fiber morphology |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070141333A1 true US20070141333A1 (en) | 2007-06-21 |
Family
ID=35125112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/594,094 Abandoned US20070141333A1 (en) | 2004-03-25 | 2005-03-17 | Emulsion-based control of electrospun fiber morphology |
Country Status (2)
Country | Link |
---|---|
US (1) | US20070141333A1 (en) |
WO (1) | WO2005098099A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060193994A1 (en) * | 2005-02-25 | 2006-08-31 | Tapani Penttinen | Priming and coating process |
US20080292839A1 (en) * | 2007-03-26 | 2008-11-27 | Mei Wei | Electrospun Apatite/Polymer Nano-Composite Scaffolds |
US20090134552A1 (en) * | 2007-11-28 | 2009-05-28 | U.S.A. as represented by the Administrator of the National Aeronautics & Space Administration | Method For Predicting and Optimizing System Parameters for Electrospinning System |
WO2016069604A1 (en) * | 2014-10-27 | 2016-05-06 | Massachusetts, University Of | Micro-and nano-particles with variable surface morphologies and methods of making same |
JP2018087402A (en) * | 2014-04-07 | 2018-06-07 | トレビラ・ゲーエムベーハー | Polymer fibers having improved dispersibility |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2455453A1 (en) * | 2006-09-06 | 2012-05-23 | Corning Incorporated | Substrate for immobilizing cells or tissue |
EP2125050B1 (en) | 2007-02-01 | 2014-07-30 | Technion Research & Development Foundation Ltd. | Albumin fibers and fabrics and methods of generating and using same |
US20100028674A1 (en) * | 2008-07-31 | 2010-02-04 | Fredrick O Ochanda | Nanofibers And Methods For Making The Same |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1975504A (en) * | 1929-12-07 | 1934-10-02 | Richard Schreiber Gastell | Process and apparatus for preparing artificial threads |
US4044404A (en) * | 1974-08-05 | 1977-08-30 | Imperial Chemical Industries Limited | Fibrillar lining for prosthetic device |
US4054625A (en) * | 1972-08-30 | 1977-10-18 | Crown Zellerbach Corporation | Process for making fibers |
US4129629A (en) * | 1974-11-28 | 1978-12-12 | Hoechst Aktiengesellschaft | Process for making hydrophilic polyolefin fibers containing clay |
US4323525A (en) * | 1978-04-19 | 1982-04-06 | Imperial Chemical Industries Limited | Electrostatic spinning of tubular products |
US4689186A (en) * | 1978-10-10 | 1987-08-25 | Imperial Chemical Industries Plc | Production of electrostatically spun products |
US20020100725A1 (en) * | 2001-01-26 | 2002-08-01 | Lee Wha Seop | Method for preparing thin fiber-structured polymer web |
US6520425B1 (en) * | 2001-08-21 | 2003-02-18 | The University Of Akron | Process and apparatus for the production of nanofibers |
US20040241436A1 (en) * | 2002-11-12 | 2004-12-02 | The Regents Of The University Of California | Nano-porous fibers and protein membranes |
US20060194036A1 (en) * | 2003-03-31 | 2006-08-31 | Keiichi Miyamoto | Molded elastin article and process for producing the same |
-
2005
- 2005-03-17 WO PCT/US2005/009048 patent/WO2005098099A1/en active Application Filing
- 2005-03-17 US US10/594,094 patent/US20070141333A1/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1975504A (en) * | 1929-12-07 | 1934-10-02 | Richard Schreiber Gastell | Process and apparatus for preparing artificial threads |
US4054625A (en) * | 1972-08-30 | 1977-10-18 | Crown Zellerbach Corporation | Process for making fibers |
US4044404A (en) * | 1974-08-05 | 1977-08-30 | Imperial Chemical Industries Limited | Fibrillar lining for prosthetic device |
US4129629A (en) * | 1974-11-28 | 1978-12-12 | Hoechst Aktiengesellschaft | Process for making hydrophilic polyolefin fibers containing clay |
US4323525A (en) * | 1978-04-19 | 1982-04-06 | Imperial Chemical Industries Limited | Electrostatic spinning of tubular products |
US4689186A (en) * | 1978-10-10 | 1987-08-25 | Imperial Chemical Industries Plc | Production of electrostatically spun products |
US20020100725A1 (en) * | 2001-01-26 | 2002-08-01 | Lee Wha Seop | Method for preparing thin fiber-structured polymer web |
US6520425B1 (en) * | 2001-08-21 | 2003-02-18 | The University Of Akron | Process and apparatus for the production of nanofibers |
US20040241436A1 (en) * | 2002-11-12 | 2004-12-02 | The Regents Of The University Of California | Nano-porous fibers and protein membranes |
US20060194036A1 (en) * | 2003-03-31 | 2006-08-31 | Keiichi Miyamoto | Molded elastin article and process for producing the same |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060193994A1 (en) * | 2005-02-25 | 2006-08-31 | Tapani Penttinen | Priming and coating process |
US8309184B2 (en) * | 2005-02-25 | 2012-11-13 | Stora Enso Oyj | Priming and coating process |
US20080292839A1 (en) * | 2007-03-26 | 2008-11-27 | Mei Wei | Electrospun Apatite/Polymer Nano-Composite Scaffolds |
US7879093B2 (en) * | 2007-03-26 | 2011-02-01 | University Of Connecticut | Electrospun apatite/polymer nano-composite scaffolds |
US20110140295A1 (en) * | 2007-03-26 | 2011-06-16 | University Of Connecticut | Electrospun Apatite/Polymer Nano-Composite Scaffolds |
US20090134552A1 (en) * | 2007-11-28 | 2009-05-28 | U.S.A. as represented by the Administrator of the National Aeronautics & Space Administration | Method For Predicting and Optimizing System Parameters for Electrospinning System |
US7901611B2 (en) | 2007-11-28 | 2011-03-08 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Method for predicting and optimizing system parameters for electrospinning system |
JP2018087402A (en) * | 2014-04-07 | 2018-06-07 | トレビラ・ゲーエムベーハー | Polymer fibers having improved dispersibility |
WO2016069604A1 (en) * | 2014-10-27 | 2016-05-06 | Massachusetts, University Of | Micro-and nano-particles with variable surface morphologies and methods of making same |
US10124310B2 (en) | 2014-10-27 | 2018-11-13 | University Of Massachusetts | Micro- and nano-particles with variable surface morphologies and methods of making same |
Also Published As
Publication number | Publication date |
---|---|
WO2005098099A1 (en) | 2005-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070141333A1 (en) | Emulsion-based control of electrospun fiber morphology | |
Elahi et al. | Core-shell fibers for biomedical applications-a review | |
Maretschek et al. | Electrospun biodegradable nanofiber nonwovens for controlled release of proteins | |
Herrero-Herrero et al. | PLA/PCL electrospun membranes of tailored fibres diameter as drug delivery systems | |
US7390452B2 (en) | Electrospinning of polymer and mesoporous composite fibers | |
Zhang et al. | Electrospinning of ultrafine core/shell fibers for biomedical applications | |
Cheng et al. | Biomedical application and controlled drug release of electrospun fibrous materials | |
US9139935B2 (en) | Electrostatic-assisted fiber spinning method and production of highly aligned and packed hollow fiber assembly and membrane | |
US8043480B2 (en) | Methods for forming biodegradable nanocomponents with controlled shapes and sizes via electrified jetting | |
Liang et al. | Functional electrospun nanofibrous scaffolds for biomedical applications | |
Dias et al. | The main blow spun polymer systems: processing conditions and applications | |
Moroni et al. | Fiber diameter and texture of electrospun PEOT/PBT scaffolds influence human mesenchymal stem cell proliferation and morphology, and the release of incorporated compounds | |
Zamani et al. | Protein encapsulated core–shell structured particles prepared by coaxial electrospraying: Investigation on material and processing variables | |
Sy et al. | Emulsion as a means of controlling electrospinning of polymers | |
US7323540B2 (en) | Process for preparing microrods using liquid-liquid dispersion | |
Wang et al. | Pollen-inspired microparticles with strong adhesion for drug delivery | |
Cao et al. | Generation of nano-sized core–shell particles using a coaxial tri-capillary electrospray-template removal method | |
US20110180951A1 (en) | Fiber structures and process for their preparation | |
WO2009055693A2 (en) | Methods for forming biodegradable nanocomponents with controlled shapes and sizes via electrified jetting | |
US20140162521A1 (en) | Electrospinning apparatus with a sideway motion device and a method of using the same | |
US20120003893A1 (en) | Composite Nanofibers | |
Mwiiri et al. | Electrospun nanofibers for biomedical applications | |
US20080213574A1 (en) | Amphiphilic Fibers and Membranes and Processes for Preparing Them | |
Pal et al. | Conducive 3D porous mesh of poly (ε-caprolactone) made via emulsion electrospinning | |
Altun et al. | The effect of solvent and pressure on polycaprolactone solutions for particle and fibre formation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THE CHILDREN'S HOSPITAL OF PHILADELPHIA, PENNSYLVA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHASTRI, VENKATRAM P.;REEL/FRAME:020482/0911 Effective date: 20080117 Owner name: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, PE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SY, JAY C.;CHEN, I-WEI;REEL/FRAME:020482/0934;SIGNING DATES FROM 20070827 TO 20070830 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |